The requirements for medical devices are changing. Since the 1990s, the core legal framework for medical devices in the EU has consisted of three directives:

• Directive 90/385/EEC regarding active implantable medical devices (AIMD)
• Directive 93/42/EEC regarding medical devices (MDD)
• Directive 98/79/EC regarding in vitro diagnostic medical devices (IVDD)

These Directives are being replaced by the new Medical Devices Regulation and IVD Regulation, published on May 5^th 2017. Until notified bodies are designated to certify against the new Regulations, all medical devices must fulfil the essential requirements set out in the above mentioned Directives. Where available, relevant standards may be used to demonstrate compliance with the essential requirements defined in the Directives list of harmonized standards.

It is important that you prepare to meet the new requirements, so you are ready for certification soon after your Notified Body is designated. You can find out more about the transition on our dedicated webpages: MDR revision or IVDR revision.

BSI is a full scope Notified Body to the Medical Device Directives. This means whatever type of device a manufacturer wishes to market in Europe, where CE marking is a legal requirement, BSI has the technical expertise to provide appropriate conformity assessment services. 

CE marking is the manufacturer's declaration that the medical device meets the appropriate regulatory requirements. To understand which requirements you need to meet, you must classify the device and identify the appropriate conformity assessment route for your product. This dictates the required activities to demonstrate conformity. We will review the route you chose to confirm its suitability, and work with you to execute the most efficient review process for the route selected. Our trusted review processess allow you to build  reliability and confidence into your CE marking project planning. 

BSI has a strong commitment to providing the most experienced and efficient routes to global markets. That is why we offer you our trusted technical documentation review service, CE-Excellence. We understand the challenges of achieving market access efficiently and safely, meeting commercial goals and regulatory requirements. Our services have been developed to support manufacturers seeking timely market access without compromise. They combine efficiency with the integrity, independence, predictability and thoroughness that you have come to expect from BSI.

Note: Our services do not guarantee a CE Marking certificate will be issued within a certain amount of working days, but are based on completing the review process with either a positive or negative recommendation. CE-Dedicated and CE-Onsite is not available for devices utilising animal tissue, blood derivatives or medicinal substances.

We can provide the following CE Marking services:

The BSI CE-Standard review service allows you to work closely with your assigned BSI Product Expert on your product certification. These reviews are conducted remotely, with communication between you and your BSI Product Expert via phone and email, as required.

The BSI CE-Dedicated review service allows you to schedule your technical documentation review with a dedicated BSI Product Expert. The review is conducted remotely via teleconferencing, allowing you to engage with your dedicated BSI Product Expert and provide immediate responses to their questions. This allows predictability in planning for the review, and can improve the efficiency of the review process.

The CE-Onsite review service is conducted at your premises; a BSI Product Expert visits the facility for a period of time. CE-Onsite reviews allow for dynamic communications and opportunities for immediate responses to questions raised by the reviewer. Planning a CE-Onsite review in advance provides you with more predictability and the reassurance of knowing when your BSI Product Expert will be at your premises.

Expansion into global markets like Europe represents a profitable future for medical device manufacturers, but this transition also requires an in-depth understanding of complicated regulatory demands and unique market challenges. With the goal of bringing your product to market in the most efficient manner possible, we can help you overcome every hurdle along the way. Our wealth of expertise across the medical device space allows you to:

• Understand the regulations of three different council directives (AIMDD, MDD and IVDD) as well as the six amending commission directives, and other additional directives
• Move past unforeseen administrative setbacks without delaying market approval
• Define unclear requirements on the quantity and quality of clinical data required
• Resolve the unclear regulatory status of a (borderline) product
• Prepare for and adjust to any new and/or revised legislation that will go into effect during your review